Show simple item record

dc.contributor.authorShahram, F
dc.contributor.authorKhabbazi, A
dc.contributor.authorNadji, A
dc.contributor.authorZiaie, N
dc.contributor.authorBanihashemi, AT
dc.contributor.authorDavatchi, F
dc.date.accessioned2018-08-26T08:50:55Z
dc.date.available2018-08-26T08:50:55Z
dc.date.issued2009
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/53143
dc.description.abstractThe objective of this study was to determine the concordance between the Iranian Behçet's disease dynamic activity measure (IBDDAM) or the Behçet's disease current activity form (BDCAF) and expert physician global assessment (PGA) in the evaluation of disease activity changes in Behçet's disease (BD). In a prospective study, 117 consecutive patients with BD were evaluated in their two consecutive follow-up visits by IBDDAM and BDCAF. The change in disease activity was determined (increased, unchanged or decreased) according to the PGA. We used receiver operating characteristic (ROC) curve to determine an appropriate cutoff point for disease activity change. Comparison was made by Stata and kappa analysis. Comparing the area under the ROC curve showed a significant difference between IBDDAM and BDCAF (p < 0.03). The difference was more significant between nonocular IBDDAM and BDCAF (p < 0.002). Better concordance was also observed for IBDDAM (nonocular and total) with PGA than BDCAF. The difference was not significant for ocular IBDDAM. The best cutoff point for nonocular IBDDAM was 0.45, for ocular IBDDAM was 3.5, and for BDCAF was 1 point. IBDDAM was the preferred method for the evaluation of disease activity change in patients with BD (without ocular involvement) considering a change of at least 0.45. é Japan College of Rheumatology 2009.
dc.language.isoEnglish
dc.relation.ispartofModern Rheumatology
dc.subjectadolescent
dc.subjectadult
dc.subjectaged
dc.subjectanalytic method
dc.subjectarticle
dc.subjectBehcet disease
dc.subjectBehcet Disease Current Activity Form
dc.subjectchild
dc.subjectclinical trial
dc.subjectcontrolled clinical trial
dc.subjectcontrolled study
dc.subjectdisease activity
dc.subjectdisease course
dc.subjectdisease severity
dc.subjectevaluation
dc.subjectexpert physician global assessment
dc.subjectfemale
dc.subjectfollow up
dc.subjecthuman
dc.subjectintermethod comparison
dc.subjectIranian Behcet disease dynamic activity measure
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectpatient assessment
dc.subjectpriority journal
dc.subjectschool child
dc.subjectAdolescent
dc.subjectAdult
dc.subjectAged
dc.subjectBehcet Syndrome
dc.subjectChild
dc.subjectDisease Progression
dc.subjectFemale
dc.subjectFollow-Up Studies
dc.subjectHumans
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectProspective Studies
dc.subjectSeverity of Illness Index
dc.titleComparison of existing disease activity indices in the follow-up of patients with Behçet's disease
dc.typeArticle
dc.citation.volume19
dc.citation.issue5
dc.citation.spage536
dc.citation.epage541
dc.citation.indexScopus
dc.identifier.DOIhttps://doi.org/10.1007/s10165-009-0191-z


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record